In 2024, it reached USD 9.5 billion, with an estimated CAGR (Compound Annual Growth Rate) of 11.7%, driven by demand for functional foods, gluten-free products, and plant-based alternatives (Acumen Research and Consulting, 2024)
A Note on Pancreatitis While rare, both heavy alcohol use and GLP-1 medications have been linked to pancreatitis
Yes, companies like Pfizer are working on oral GLP-1 formulations, which could improve convenience for patients reluctant to use injectables
What This Means in Practice The Bridge runs through December 31, 2027
Youll then answer questions about your age, family, and personal health history to determine if you qualify for GLP-1s